Lane, Thirusha

Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature. [electronic resource] - Clinical and experimental rheumatology - S46-53 p. digital

Publication Type: Journal Article; Review

0392-856X


Adolescent
Adult
Amyloidosis--blood
Anti-Inflammatory Agents--adverse effects
Antibodies, Monoclonal, Humanized--adverse effects
Biomarkers--blood
Child
Chronic Disease
Databases, Factual
Down-Regulation
Female
Humans
Immunocompromised Host
Inflammation--blood
Interleukin-6--antagonists & inhibitors
Male
Middle Aged
Opportunistic Infections--chemically induced
Quality of Life
Receptors, Interleukin-6--antagonists & inhibitors
Remission Induction
Risk Factors
Serum Amyloid A Protein--metabolism
Signal Transduction--drug effects
Surveys and Questionnaires
Time Factors
Treatment Outcome
Young Adult